Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-000658

Chief Financial Officer acquired 196,216 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gabay Avraham · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2025-12-31 Grant or award : show line 1 in the form +81,216 515,256 D
2025-12-31 Grant or award : show line 2 in the form +115,000 630,256 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-31 Grant or award : show line 3 in the form Performance Stock Units +19,000 19,000 D
Loading xslF345X05/ownership.xml…